Back to Journals » ImmunoTargets and Therapy » Volume 4

Update on use of aldesleukin for treatment of high-risk metastatic melanoma

Total article views   HTML views PDF downloads Totals
16,713 Dovepress* 12,216+ 2,009 14,225
PubMed Central* 4,497 628 5,125
Totals 16,713 2,637 19,350
*Since 7 April 2015
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed Central and Google Scholar